Study on the Effect of Target-controlled Infusion for General Anesthesia in Cardiac Surgery

NCT ID: NCT06012955

Last Updated: 2023-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-30

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study was to evaluate whether individualized general anesthesia with target-controlled infusion could help patients wake up early for extubation and reduce the incidence of postoperative complications, and to investigate the effectiveness and safety of its application in patients undergoing cardiac surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Mechanical Ventilation Time

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TCI group

patients receiving general anesthesia using target-controlled infusion delivery system

Target-controlled infusion (TCI) systems

Intervention Type DEVICE

Target-controlled infusion (TCI) with propofol and remifentanil was used for anesthesia induction and maintenance

MCI group

patients receiving general anesthesia using conventional manual controlled infusion delivery

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Target-controlled infusion (TCI) systems

Target-controlled infusion (TCI) with propofol and remifentanil was used for anesthesia induction and maintenance

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients aged 18 years and older who underwent cardiac surgery

Exclusion Criteria

* Mechanical ventilation support before surgery;
* Combined with any type of non-cardiac surgeries;
* Second exploratory thoracotomy after surgery;
* Died or discharged within 48 h after surgery;
* Missing clinical data
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wuhan Union Hospital

Wuhan, Hubei, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Qingping Wu

Role: CONTACT

13971605283

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Qingping Wu

Role: primary

13971605283

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TCI202112

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.